Skip to main content
Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis.
Published Web Location
http://europepmc.org/articles/PMC4186432?pdf=renderNo data is associated with this publication.
Abstract
BACKGROUND: Selective disruption of the spleen tyrosine kinase (Syk) represents a novel strategy to control B-cell functional responses by inhibition of B-cell antigen receptor (BCR) signaling. PRT062607 (P505-15) is a highly selective small molecule Syk i
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.